Targeting triple negative breast cancer: Is p53 the answer?-Reference-Cited by-同舟云学术

Targeting triple negative breast cancer: Is p53 the answer?

Published:2013-08 Issue:5 Volume:39 Page:541-550
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

Turner Natalie,Moretti Erica,Siclari Olimpia,Migliaccio Ilenia,Santarpia Libero,D’Incalci Maurizio,Piccolo Stefano,Veronesi Andrea,Zambelli Alberto,Del Sal Gianni,Di Leo Angelo

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Reference97 articles.

1. Management of triple negative breast cancer;Oakman;Breast,2010

2. Molecular portraits of human breast tumours;Perou;Nature,2000

3. Iniparib plus chemotherapy in metastatic triple-negative breast cancer;O’Shaughnessy;N Engl J Med,2011

4. Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study;Gelmon;Lancet Oncol,2011

5. TBCRC 001: randomized phase II study of cetuximab in combination with carboplatin in stage IV triple-negative breast cancer;Carey;J Clin Oncol,2012

Cited by 105 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The treatment landscape of triple-negative breast cancer;Medical Oncology;2024-08-29

2. Indolent triple negative breast cancer;Clinical Case in Oncology;2024-03-25

3. Triple-Negative Breast Cancer and Emerging Therapeutic Strategies: ATR and CHK1/2 as Promising Targets;Cancers;2024-03-13

4. CRUX, a platform for visualising, exploring and analysing cancer genome cohort data;NAR Genomics and Bioinformatics;2024-01-05

5. Exploiting Long Non-Coding RNAs and Circular RNAs as Pharmacological Targets in Triple-Negative Breast Cancer Treatment;Cancers;2023-08-20